Skip to main content

Table 1 ANOVA table for retention time

From: A Design of Experiment (DoE) based approach for development and optimization of nanosuspensions of telmisartan, a BCS class II antihypertensive drug

Source

Sum of squares

df

Mean square

F value

p value

 

Model

2.48

3

0.83

107.77

< 0.0001

Significant

 A-FR

0.24

1

0.24

31.27

0.0008

 B-pH

2.08

1

2.08

272.01

< 0.0001

 AB

0.15

1

0.15

20.04

0.0029

Curvature

0.89

1

0.89

115.95

< 0.0001

Pure error

0.054

7

7.657E−003

  

Cor total

3.42

11